Cargando…
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signaling and protein synthesis
Glypican-3 is a cell surface glycoprotein that associates with Wnt in liver cancer. We develop two antibodies targeting glypican-3, HN3 and YP7. The first antibody recognizes a functional epitope and inhibits Wnt signaling, whereas the second antibody recognizes a C-terminal epitope but does not inh...
Autores principales: | Gao, Wei, Tang, Zhewei, Zhang, Yifan, Feng, Mingqian, Qian, Min, Dimitrov, Dimiter S., Ho, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357278/ https://www.ncbi.nlm.nih.gov/pubmed/25758784 http://dx.doi.org/10.1038/ncomms7536 |
Ejemplares similares
-
Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
por: Fleming, Bryan D., et al.
Publicado: (2016) -
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
por: Wang, Chunguang, et al.
Publicado: (2016) -
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
por: Fleming, Bryan D., et al.
Publicado: (2020) -
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
por: Kolluri, Aarti, et al.
Publicado: (2019) -
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
por: Liu, Xiaoyu, et al.
Publicado: (2020)